menopausal disorders	include	vasomotor symptoms
menopausal disorders	associated with	estrogen deficiency
estrogen deficiency	causes	vaginal atrophy
estrogen deficiency	causes	osteoporosis
osteoporosis	increases risk of	fracture
vaginal atrophy	causes	dyspareunia
dyspareunia	associated with	vaginal dryness
vaginal dryness	leads to	urinary symptoms
vasomotor symptoms	include	hot flashes
vasomotor symptoms	include	night sweats
hot flashes	disrupts	sleep
night sweats	disrupts	sleep
sleep disturbance	associated with	mood changes
mood changes	associated with	depression
depression	affects	quality of life
estrogen deficiency	increases	cardiovascular risk
postmenopausal status	associated with	osteoporosis
calcium supplementation	reduces	fracture risk
vitamin D	supports	bone health
bone health	improves with	weight-bearing exercise
weight-bearing exercise	reduces	osteoporosis progression
bisphosphonates	treat	osteoporosis
alendronate	is a	bisphosphonate
hormone therapy	treats	vasomotor symptoms
hormone therapy	increases risk of	breast cancer
phytoestrogens	used for	menopausal symptom relief
nonhormonal therapy	used for	vasomotor symptoms
calcium	supports	bone health
smoking	increases	vasomotor symptoms severity
obesity	associated with	vasomotor symptoms severity
perimenopause	characterized by	fluctuating hormones
perimenopause	precedes	menopause
bone mineral density	measured by	DEXA scan
DEXA scan	shows	bone loss
estrogen withdrawal	reduces	endometrial cancer risk
estrogen deficiency	predisposes to	vaginal infections
urinary tract infection	more common in	postmenopausal women
vaginal pH changes	associated with	vaginal infections
urinary incontinence	worsens with	menopause
hot flashes	last	several minutes
night sweats	occur with	sleep disturbance
sleep disturbance	increases	daytime fatigue
daytime fatigue	reduces	work performance
bone turnover	increases with	age
FSH elevation	indicates	menopause
LH elevation	accompanies	menopause
endometrial atrophy	results from	estrogen deficiency
bone mineral density	declines with	estrogen deficiency
hot flashes	may persist despite	nonhormonal therapy
vaginal dryness	improves with	vaginal estrogen therapy
vaginal estrogen therapy	is used for	vulvovaginal atrophy
calcium supplementation	recommended for	bone health
osteoporosis	risk increased by	smoking
osteoporosis	risk increased by	alcohol use
vitamin D deficiency	associated with	osteoporosis
bisphosphonates	reduce	fracture risk
calcitonin	used for	osteoporosis
teriparatide	used for	osteoporosis
hormone therapy	contraindicated in	history of thromboembolism
breast cancer	risk increases with	hormone therapy
menopause	associated with	cardiovascular disease risk
cardiovascular disease	increases mortality in	postmenopausal women
estrogen therapy	improves	vaginal atrophy
endometrium	becomes atrophic in	menopause
estrogen deficiency	leads to	endometrial thinning
menstrual cessation	marks	menopause
vulvovaginal atrophy	causes	urinary symptoms
pelvic floor weakness	increases risk of	urinary incontinence
genitourinary syndrome of menopause	is defined by	vaginal dryness
genitourinary syndrome of menopause	is diagnosed by	symptoms
vaginal infections	more common in	menopause
sleep quality	worsens with	hot flashes
vaginal lubricants	used for	vaginal dryness
topical estrogen	used for	vaginal atrophy
estrogen replacement therapy	has effect on	lipid profile
lipid profile	worsens during	menopause
cholesterol	increases after	menopause
metabolic syndrome	associated with	menopause
mood disorders	more frequent in	perimenopause
cognitive function	may be affected by	menopause
hot flashes	correlate with	sleep disturbance severity
fatigue	correlates with	mood disturbances
physical activity	improves	mood in menopause
calcium intake	necessary for	bone maintenance
fracture risk	decreases with	weight-bearing exercise
weight gain	associated with	menopause
estrogen deficiency	contributes to	skin aging
skin elasticity	decreases with	menopause
hair thinning	occurs in	menopause
aging	accelerates	bone loss
physical therapy	helps with	pelvic floor function
urinary urgency	common in	postmenopause
vaginal pH	increases with	vaginal atrophy
hormone replacement therapy	requires	monitoring
osteoporosis screening	recommended for	postmenopausal women
DEXA test	used for	osteoporosis screening
serum FSH	elevated in	menopause
LH	increases during	menopause
reproductive aging	encompasses	menopausal disorders
menopause transition	overlaps with	perimenopause
